Literature DB >> 20940144

Rapid and transient recruitment of DNMT1 to DNA double-strand breaks is mediated by its interaction with multiple components of the DNA damage response machinery.

Kyungsoo Ha1, Gun Eui Lee, Stela S Palii, Kevin D Brown, Yoshihiko Takeda, Kebin Liu, Kapil N Bhalla, Keith D Robertson.   

Abstract

DNA methylation is an epigenetic mark critical for regulating transcription, chromatin structure and genome stability. Although many studies have shed light on how methylation impacts transcription and interfaces with the histone code, far less is known about how it regulates genome stability. We and others have shown that DNA methyltransferase 1 (DNMT1), the maintenance methyltransferase, contributes to the cellular response to DNA damage, yet DNMT1's exact role in this process remains unclear. DNA damage, particularly in the form of double-strand breaks (DSBs), poses a major threat to genome integrity. Cells therefore possess a potent system to respond to and repair DSBs, or to initiate cell death. In the current study, we used a near-infrared laser microirradiation system to directly study the link between DNMT1 and DSBs. Our results demonstrate that DNMT1 is rapidly but transiently recruited to DSBs. DNMT1 recruitment is dependent on its ability to interact with both PCNA and the ATR effector kinase CHK1, but is independent of its catalytic activity. In addition, we show for the first time that DNMT1 interacts with the 9-1-1 PCNA-like sliding clamp and that this interaction also contributes to DNMT1 localization to DNA DSBs. Finally, we demonstrate that DNMT1 modulates the rate of DSB repair and is essential for suppressing abnormal activation of the DNA damage response in the absence of exogenous damage. Taken together, our studies provide compelling additional evidence for DNMT1 acting as a regulator of genome integrity and as an early responder to DNA DSBs.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20940144      PMCID: PMC3000680          DOI: 10.1093/hmg/ddq451

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  75 in total

1.  Loading of the human 9-1-1 checkpoint complex onto DNA by the checkpoint clamp loader hRad17-replication factor C complex in vitro.

Authors:  Vladimir P Bermudez; Laura A Lindsey-Boltz; Anthony J Cesare; Yoshimasa Maniwa; Jack D Griffith; Jerard Hurwitz; Aziz Sancar
Journal:  Proc Natl Acad Sci U S A       Date:  2003-02-10       Impact factor: 11.205

2.  Repeated phosphopeptide motifs in Claspin mediate the regulated binding of Chk1.

Authors:  Akiko Kumagai; William G Dunphy
Journal:  Nat Cell Biol       Date:  2003-02       Impact factor: 28.824

3.  UHRF1 plays a role in maintaining DNA methylation in mammalian cells.

Authors:  Magnolia Bostick; Jong Kyong Kim; Pierre-Olivier Estève; Amander Clark; Sriharsa Pradhan; Steven E Jacobsen
Journal:  Science       Date:  2007-08-02       Impact factor: 47.728

4.  Specific role of Chk1 phosphorylations in cell survival and checkpoint activation.

Authors:  Hiroyuki Niida; Yuko Katsuno; Birendranath Banerjee; M Prakash Hande; Makoto Nakanishi
Journal:  Mol Cell Biol       Date:  2007-01-22       Impact factor: 4.272

5.  DNMT1 knockout delivers a strong blow to genome stability and cell viability.

Authors:  Kevin D Brown; Keith D Robertson
Journal:  Nat Genet       Date:  2007-03       Impact factor: 38.330

Review 6.  PCNA, the maestro of the replication fork.

Authors:  George-Lucian Moldovan; Boris Pfander; Stefan Jentsch
Journal:  Cell       Date:  2007-05-18       Impact factor: 41.582

7.  Human cancer cells require ATR for cell cycle progression following exposure to ionizing radiation.

Authors:  P J Hurley; D Wilsker; F Bunz
Journal:  Oncogene       Date:  2006-10-16       Impact factor: 9.867

8.  UCN-01 inhibits p53 up-regulation and abrogates gamma-radiation-induced G(2)-M checkpoint independently of p53 by targeting both of the checkpoint kinases, Chk2 and Chk1.

Authors:  Qiang Yu; JiHyun La Rose; Hongliang Zhang; Haruyuki Takemura; Kurt W Kohn; Yves Pommier
Journal:  Cancer Res       Date:  2002-10-15       Impact factor: 12.701

9.  PCNA clamp facilitates action of DNA cytosine methyltransferase 1 on hemimethylated DNA.

Authors:  Tetsuo Iida; Isao Suetake; Shoji Tajima; Hiroshi Morioka; Satoshi Ohta; Chikashi Obuse; Toshiki Tsurimoto
Journal:  Genes Cells       Date:  2002-10       Impact factor: 1.891

10.  Dynamics of Dnmt1 interaction with the replication machinery and its role in postreplicative maintenance of DNA methylation.

Authors:  Lothar Schermelleh; Andrea Haemmer; Fabio Spada; Nicole Rösing; Daniela Meilinger; Ulrich Rothbauer; M Cristina Cardoso; Heinrich Leonhardt
Journal:  Nucleic Acids Res       Date:  2007-06-18       Impact factor: 16.971

View more
  45 in total

1.  PML Recruits TET2 to Regulate DNA Modification and Cell Proliferation in Response to Chemotherapeutic Agent.

Authors:  Chengli Song; Lina Wang; Xiaoyan Wu; Kai Wang; Dan Xie; Qi Xiao; Songyu Li; Kui Jiang; Lujian Liao; John R Yates; Jiing-Dwan Lee; Qingkai Yang
Journal:  Cancer Res       Date:  2018-05-07       Impact factor: 12.701

Review 2.  Targeting the epigenome in malignant pleural mesothelioma.

Authors:  Kaitlin C McLoughlin; Andrew S Kaufman; David S Schrump
Journal:  Transl Lung Cancer Res       Date:  2017-06

3.  Changes in one-carbon metabolism and DNA methylation in the hearts of mice exposed to space environment-relevant doses of oxygen ions (16O).

Authors:  Isabelle R Miousse; Charles M Skinner; Vijayalakshmi Sridharan; John W Seawright; Preeti Singh; Reid D Landes; Amrita K Cheema; Martin Hauer-Jensen; Marjan Boerma; Igor Koturbash
Journal:  Life Sci Space Res (Amst)       Date:  2019-05-31

4.  ATRX contributes to epigenetic asymmetry and silencing of major satellite transcripts in the maternal genome of the mouse embryo.

Authors:  Rabindranath De La Fuente; Claudia Baumann; Maria M Viveiros
Journal:  Development       Date:  2015-04-29       Impact factor: 6.868

5.  Folate deficiency exacerbates apoptosis by inducing hypomethylation and resultant overexpression of DR4 together with altering DNMTs in Alzheimer's disease.

Authors:  Yun Wang; Shunliang Xu; Yanjun Cao; Zhaohong Xie; Chao Lai; Xiaowei Ji; Jianzhong Bi
Journal:  Int J Clin Exp Med       Date:  2014-08-15

Review 6.  Epigenetics and B-cell lymphoma.

Authors:  Rita Shaknovich; Ari Melnick
Journal:  Curr Opin Hematol       Date:  2011-07       Impact factor: 3.284

7.  An Effective Epigenetic-PARP Inhibitor Combination Therapy for Breast and Ovarian Cancers Independent of BRCA Mutations.

Authors:  Nicholas Pulliam; Fang Fang; Ali R Ozes; Jessica Tang; Adeoluwa Adewuyi; Harold Keer; John Lyons; Stephen B Baylin; Daniela Matei; Harikrishna Nakshatri; Feyruz V Rassool; Kathy D Miller; Kenneth P Nephew
Journal:  Clin Cancer Res       Date:  2018-04-03       Impact factor: 12.531

8.  DNA methyltransferase 1 and DNA methylation patterning contribute to germinal center B-cell differentiation.

Authors:  Rita Shaknovich; Leandro Cerchietti; Lucas Tsikitas; Matthias Kormaksson; Subhajyoti De; Maria E Figueroa; Gianna Ballon; Shao Ning Yang; Nils Weinhold; Mark Reimers; Thomas Clozel; Karin Luttrop; Tomas J Ekstrom; Jared Frank; Aparna Vasanthakumar; Lucy A Godley; Franziska Michor; Olivier Elemento; Ari Melnick
Journal:  Blood       Date:  2011-08-09       Impact factor: 22.113

9.  Aberrant methylation of hypermethylated-in-cancer-1 and exocyclic DNA adducts in tobacco smokers.

Authors:  Marco E M Peluso; Armelle Munnia; Valentina Bollati; Petcharin Srivatanakul; Adisorn Jedpiyawongse; Suleeporn Sangrajrang; Marcello Ceppi; Roger W Giese; Paolo Boffetta; Andrea A Baccarelli
Journal:  Toxicol Sci       Date:  2013-10-23       Impact factor: 4.849

10.  DNA Methylation Dynamics of Germinal Center B Cells Are Mediated by AID.

Authors:  Pilar M Dominguez; Matt Teater; Nyasha Chambwe; Matthias Kormaksson; David Redmond; Jennifer Ishii; Bao Vuong; Jayanta Chaudhuri; Ari Melnick; Aparna Vasanthakumar; Lucy A Godley; F Nina Papavasiliou; Olivier Elemento; Rita Shaknovich
Journal:  Cell Rep       Date:  2015-09-10       Impact factor: 9.423

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.